S872 CARFILZOMIB LENALIDOMIDE DEXAMETHASONE (KRD) WITH OR WITHOUT TRANSPLANTATION IN NEWLY DIAGNOSED MYELOMA (FORTE TRIAL): EFFICACY ACCORDING TO RISK STATUS
- Resource Type
- Source
- HemaSphere. 3:390-391
- Subject
Oncology Risk status medicine.medical_specialty business.industry Hematology Newly diagnosed Carfilzomib Transplantation chemistry.chemical_compound chemistry Internal medicine medicine business Dexamethasone medicine.drug Lenalidomide - Language
- ISSN
- 2572-9241